<--- Back to Details
First PageDocument Content
Biology / Medicine / TRPV1 / Hyperalgesia / Allodynia / Transient receptor potential cation channel /  member A1 / Neuropathic pain / Itch / Ketamine / Pain / Ion channels / Chemistry
Date: 2015-04-07 16:02:11
Biology
Medicine
TRPV1
Hyperalgesia
Allodynia
Transient receptor potential cation channel
member A1
Neuropathic pain
Itch
Ketamine
Pain
Ion channels
Chemistry

Microsoft Word - Session_05_Pain and Nociception.doc

Add to Reading List

Source URL: www.sbfte.org.br

Download Document from Source Website

File Size: 418,55 KB

Share Document on Facebook

Similar Documents

Pain Physician 2016; 19:E121-E128 • ISSNProspective Evaluation A Novel Mini-invasive Approach to the Treatment of Neuropathic Pain: The PENS Study

DocID: 1u8Bv - View Document

Pain Medicine 2011; 12: 1515–1522 Wiley Periodicals, Inc. NEUROPATHIC PAIN SECTION Original Research Articles Randomized Double-Blind Sham-Controlled

DocID: 1tU4Z - View Document

Neurochemistry / Chemistry / Nervous system / Amines / Pain / Eli Lilly and Company / Serotonin-norepinephrine reuptake inhibitors / RTT / Neuropathic pain / Opioid / Cancer pain / Analgesic

Neuropathic pain in Palliative Care How do we treat it and do we really know what we are doing?

DocID: 1ri9T - View Document

Pain / Clinical medicine / Medicine / Neuropathic pain / Hyperalgesia / Analgesic / Nervous system / Palmitoylethanolamide

4|P age Alcoholic extract of Banaba leaf prevents chronic constriction injury induced neuropathic pain in experimental animals KIRAN HARIBHAU BHOKARE , AMAN BABANRAO 1

DocID: 1r9Kd - View Document

Medicine / Clinical medicine / Cell biology / Cytokines / Microglia / Chemotherapy-induced peripheral neuropathy / Neuropathic pain / CX3CR1 / Tumor necrosis factor alpha / Chemokine / Cannabinoid receptor / Peripheral neuropathy

Regulation of Spinal Fractalkine/CX3CR1 and TNF-alpha Signaling in Paclitaxel Induced Peripheral Neuropathy in Rats Chemotherapy-induced peripheral neuropathy (CIPN) is a common, potentially severe and dose-limiting adve

DocID: 1qSei - View Document